Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy.

Sultan SM, Ng KP, Edwards JC, Isenberg DA, Cambridge G.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):887-93.

PMID:
19032824
2.

Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies.

Muñoz-Beamud F, Isenberg DA.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):896-903. Epub 2013 Sep 18.

PMID:
24050676
3.
4.

Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.

Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ.

Arthritis Rheum. 2007 Sep;56(9):3107-11.

PMID:
17763414
5.

Rituximab in the treatment of dermatomyositis: an open-label pilot study.

Levine TD.

Arthritis Rheum. 2005 Feb;52(2):601-7.

PMID:
15692974
6.

Rituximab in the treatment of refractory dermatomyositis.

Chiappetta N, Steier J, Gruber B.

J Clin Rheumatol. 2005 Oct;11(5):264-6.

PMID:
16357773
7.

Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients.

Majmudar S, Hall HA, Zimmermann B.

J Clin Rheumatol. 2009 Oct;15(7):338-40. doi: 10.1097/RHU.0b013e3181bb8e70. Review.

PMID:
20009968
8.

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.

Ann Rheum Dis. 2008 Jul;67(7):1011-6. Epub 2007 Oct 25.

PMID:
17962238
9.

Rituximab as therapy for refractory polymyositis and dermatomyositis.

Noss EH, Hausner-Sypek DL, Weinblatt ME.

J Rheumatol. 2006 May;33(5):1021-6. Epub 2006 Mar 15.

PMID:
16541475
10.

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.

Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.

Arthritis Rheum. 2009 Apr 15;61(4):482-7. doi: 10.1002/art.24341.

PMID:
19333973
11.

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE.

Ann Rheum Dis. 2008 Dec;67(12):1670-7. doi: 10.1136/ard.2007.077974. Epub 2008 Feb 13.

PMID:
18272672
12.

Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.

Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L.

Arthritis Care Res (Hoboken). 2010 Sep;62(9):1328-34. doi: 10.1002/acr.20219.

13.

A pilot trial of rituximab in the treatment of patients with dermatomyositis.

Chung L, Genovese MC, Fiorentino DF.

Arch Dermatol. 2007 Jun;143(6):763-7.

PMID:
17576943
14.

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.

Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.

Arthritis Rheum. 2005 Aug;52(8):2439-46.

PMID:
16052580
15.

Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.

Bronner IM, Hoogendijk JE, Wintzen AR, van der Meulen MF, Linssen WH, Wokke JH, de Visser M.

J Neurol. 2003 Apr;250(4):480-5.

PMID:
12700915
16.
17.

Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy.

Walsh CA, Fearon U, FitzGerald O, Veale DJ, Bresnihan B.

Clin Exp Rheumatol. 2008 Jul-Aug;26(4):656-8.

PMID:
18799100
18.

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.

Roll P, Dörner T, Tony HP.

Arthritis Rheum. 2008 Jun;58(6):1566-75. doi: 10.1002/art.23473.

PMID:
18512772
19.

[Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].

Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Tonello M, Bendo R, Rondinone R, Cozzi F, Doria A.

Reumatismo. 2005 Jan-Mar;57(1):22-8. Italian.

PMID:
15776143
20.

Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.

Marie I, Dominique S, Janvresse A, Levesque H, Menard JF.

Respir Med. 2012 Apr;106(4):581-7. doi: 10.1016/j.rmed.2012.01.001. Epub 2012 Jan 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk